Christophe LEGENDRE
Assistance Publique - Hôpitaux de Paris · Service de Transplantation Rénale, Hôpital Necker Université Paris Descartes 149 rue de Sèvres 75015 Paris, France · Hôpital Necker (AP-HP)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christophe LEGENDRE as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:11 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02201576 · Bortezomib in Rejection of Kidney TransplantsAssistance Publique - Hôpitaux de Paris · completed · Chronic Antibody-mediated Transplant Rejection · study chair
- Ph1/Ph2NCT02113891 · Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney TransplantationAssistance Publique - Hôpitaux de Paris · withdrawn · Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation · study director
- Ph4NCT01541176 · Absence of Steroid in Renal Transplantation and Digital Fibrosis ObservationNantes University Hospital · completed · Renal Transplant · study chair
- Ph3NCT01292525 · Protocol Calcineurin Inhibitor (CNI) WeaningNantes University Hospital · terminated · Function of Renal Transplant · study chair
- N/ANCT00746057 · Evaluation of an Early Screening Test of Chronic Rejection and of Operational Tolerance by MicroArray in Renal Graft (Protocol DPRC Array)Nantes University Hospital · terminated · First Cadaveric Renal Graft · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:11 UTC. The ranking covers the 200 most relevant of 80 PubMed records, and a shared surname and initials can bring in a namesake. All 80 on PubMed
- 1,234 citationsRCR 41.4
- Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.N Engl J Med · 1999552 citationsRCR 16.9
- 440 citationsRCR 16.3
- Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies.Kidney Int · 2015317 citationsRCR 12.6
- Optimization of initial tacrolimus dose using pharmacogenetic testing.Clin Pharmacol Ther · 2010306 citationsRCR 9.8
- 303 citationsRCR 14.9
- Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.Lancet · 1996299 citationsRCR 12.0
- Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.Am J Kidney Dis · 2016254 citationsRCR 11.0
- Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.J Am Soc Nephrol · 2018212 citationsRCR 10.7
- Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.Transplantation · 2005196 citationsRCR 6.1